| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.8 |